3,4-MDO-U-47700

3,4-MDO-U-47700 is a synthetic opioid that is a derivative of the more well-known opioid, U-47700. It is a novel psychoactive substance, meaning it is a new or relatively unknown substance with psychoactive properties.

Chemistry

3,4-MDO-U-47700 is a structural isomer of U-47700, meaning it has the same molecular formula but a different arrangement of atoms. It is part of the benzamide class of opioids and is structurally related to earlier benzamide opioids such as U-50488 and AH-7921.

Pharmacology

As a synthetic opioid, 3,4-MDO-U-47700 acts on the mu-opioid receptor, which is the same receptor targeted by natural opioids like morphine and synthetic opioids like fentanyl. The mu-opioid receptor is involved in pain relief, euphoria, and respiratory depression, which are all effects of opioid use.

Effects

The effects of 3,4-MDO-U-47700 are similar to other opioids and include pain relief, sedation, and euphoria. However, as a novel psychoactive substance, the exact effects and safety profile of 3,4-MDO-U-47700 are not well known.

Legal Status

The legal status of 3,4-MDO-U-47700 varies by country. In some countries, it is a controlled substance, while in others it is not regulated.

Risks

As with all opioids, there are significant risks associated with the use of 3,4-MDO-U-47700. These include addiction, overdose, and death. The risk of these outcomes is likely increased due to the lack of information about the substance's effects and safety profile.

See Also

• U-47700
• Synthetic opioids
• Novel psychoactive substances